Cargando…

Estrogen Receptor β4 Regulates Chemotherapy Resistance and Induces Cancer Stem Cells in Triple Negative Breast Cancer

Triple Negative Breast Cancer (TNBC) has the worst prognosis among all breast cancers, and survival in patients with recurrence is rarely beyond 12 months due to acquired resistance to chemotherapy, which is the standard of care for these patients. Our hypothesis is that Estrogen Receptor β1 (ERβ1)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bano, Ayesha, Stevens, Jessica H., Modi, Paulomi S., Gustafsson, Jan-Åke, Strom, Anders M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058198/ https://www.ncbi.nlm.nih.gov/pubmed/36982940 http://dx.doi.org/10.3390/ijms24065867

Ejemplares similares

The estrogen receptor variants β2 and β5 induce stem cell characteristics and chemotherapy resistance in prostate cancer through activation of hypoxic signaling
por: Faria, Michelle, et al.
Publicado: (2018)

Estrogen receptor β2 induces proliferation and invasiveness of triple negative breast cancer cells: association with regulation of PHD3 and HIF-1α
por: Bialesova, Lucia, et al.
Publicado: (2017)

Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity
por: Chaurasiya, Surendra, et al.
Publicado: (2020)

Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer
por: Sellitto, Assunta, et al.
Publicado: (2020)

ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function
por: Bado, Igor, et al.
Publicado: (2016)

Estrogen Actions in Triple-Negative Breast Cancer
por: Treeck, Oliver, et al.
Publicado: (2020)

Estrogen receptor β: an overview and update
por: Zhao, Chunyan, et al.
Publicado: (2008)

Estrogen Receptor β2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1α in Prostate Cancer
por: Dey, Prasenjit, et al.
Publicado: (2015)

Correction: Estrogen Receptor β2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1α in Prostate Cancer
por: Dey, Prasenjit, et al.
Publicado: (2015)

Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
por: van Barele, Mark, et al.
Publicado: (2021)

Estrogen receptor transcription and transactivation: Basic aspects of estrogen action
por: Nilsson , Stefan, et al.
Publicado: (2000)

Hes-6, an inhibitor of Hes-1, is regulated by 17β-estradiol and promotes breast cancer cell proliferation
por: Hartman, Johan, et al.
Publicado: (2009)

Metronomic chemotherapy for triple negative breast cancer?
por: Di Desidero, Teresa, et al.
Publicado: (2016)

Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells
por: Chen, Xingxing, et al.
Publicado: (2017)

Clinicopathological Characteristics of Estrogen Receptor‐(3‐positive Human Breast Cancers
por: Miyoshi, Yasuo, et al.
Publicado: (2001)

Biologic Roles of Estrogen Receptor-β and Insulin-Like Growth Factor-2 in Triple-Negative Breast Cancer
por: Hamilton, Nalo, et al.
Publicado: (2015)

Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro
por: Schüler-Toprak, Susanne, et al.
Publicado: (2016)

Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy
por: Dieci, Maria Vittoria, et al.
Publicado: (2021)

Triple-negative breast cancer that progressed as estrogen receptor-positive skin metastases
por: Lee, Sang Min, et al.
Publicado: (2015)

Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells
por: Tian, Jun, et al.
Publicado: (2018)

RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer
por: Fernández, Natalia B., et al.
Publicado: (2023)

Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma
por: Sareddy, Gangadhara R., et al.
Publicado: (2016)

Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer
por: Hollmén, Maija, et al.
Publicado: (2015)

Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer
por: Tian, Jun, et al.
Publicado: (2017)

Estrogen receptor and aryl hydrocarbon receptor signaling pathways
por: Matthews, Jason, et al.
Publicado: (2006)

Metabolic Actions of Estrogen Receptor Beta (ERβ) are Mediated by a Negative Cross-Talk with PPARγ
por: Foryst-Ludwig, Anna, et al.
Publicado: (2008)

Estrogen receptor-beta is a potential target for triple negative breast cancer treatment
por: Austin, David, et al.
Publicado: (2018)

Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival
por: Takano, Elena A., et al.
Publicado: (2023)

Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer
por: Si, Yingnan, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: An Observational Study
por: Shao, Zhiying, et al.
Publicado: (2016)

Genomic Index of Sensitivity to Chemotherapy for Triple Negative Breast Cancer
por: C, Ahammad Sameer, et al.
Publicado: (2023)

Platinum‐based chemotherapy for early triple‐negative breast cancer
por: Mason, Sofia RE, et al.
Publicado: (2023)

Effects of two common polymorphisms in the 3' untranslated regions of estrogen receptor β on mRNA stability and translatability
por: Putnik, Milica, et al.
Publicado: (2009)

Antidiabetic Actions of an Estrogen Receptor β Selective Agonist
por: Alonso-Magdalena, Paloma, et al.
Publicado: (2013)

Location of Triple-Negative Breast Cancers: Comparison with Estrogen Receptor-Positive Breast Cancers on MR Imaging
por: Kim, Won Hwa, et al.
Publicado: (2015)

Liver X receptors and estrogen receptor β, two players in a rare subtype of NSCLC
por: Wu, Wanfu, et al.
Publicado: (2023)

Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity
por: Lindberg, Karolina, et al.
Publicado: (2011)

Role of High-Dose Adjuvant Chemotherapy Followed by Autologous Stem Cell Transplantation in Locally Advanced Triple-Negative Breast Cancer: A Retrospective Chart Review
por: Al-Share, Bayan, et al.
Publicado: (2022)

Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
por: Park, So-Yeon, et al.
Publicado: (2019)

Regulation of cancer stem cells in triple negative breast cancer
por: Fultang, Norman, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r2b39gq9eberrovil7olucmk0a